BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23538711)

  • 1. Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution.
    Chambliss AB; Wu PH; Chen WC; Sun SX; Wirtz D
    FASEB J; 2013 Jul; 27(7):2667-76. PubMed ID: 23538711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
    Mathew OP; Ranganna K; Yatsu FM
    Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.
    Bártová E; Pacherník J; Harnicarová A; Kovarík A; Kovaríková M; Hofmanová J; Skalníková M; Kozubek M; Kozubek S
    J Cell Sci; 2005 Nov; 118(Pt 21):5035-46. PubMed ID: 16254244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interplay between the cell cycle and cell phenotypes.
    Chen WC; Wu PH; Phillip JM; Khatau SB; Choi JM; Dallas MR; Konstantopoulos K; Sun SX; Lee JS; Hodzic D; Wirtz D
    Integr Biol (Camb); 2013 Mar; 5(3):523-34. PubMed ID: 23319145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin flow cytometry identifies changes in epigenetic cell states.
    Obier N; Müller AM
    Cells Tissues Organs; 2010; 191(3):167-74. PubMed ID: 19776550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
    J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.
    Taddei A; Maison C; Roche D; Almouzni G
    Nat Cell Biol; 2001 Feb; 3(2):114-20. PubMed ID: 11175742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte.
    Yang F; Baumann C; Viveiros MM; De La Fuente R
    Int J Dev Biol; 2012; 56(10-12):889-99. PubMed ID: 23417411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoporins redistribute inside the nucleus after cell cycle arrest induced by histone deacetylases inhibition.
    Pérez-Garrastachu M; Arluzea J; Andrade R; Díez-Torre A; Urtizberea M; Silió M; Aréchaga J
    Nucleus; 2017 Sep; 8(5):515-533. PubMed ID: 28696859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
    Richon VM; Sandhoff TW; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry.
    Krautkramer KA; Reiter L; Denu JM; Dowell JA
    J Proteome Res; 2015 Aug; 14(8):3252-62. PubMed ID: 26120868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts.
    Ji P; Yeh V; Ramirez T; Murata-Hori M; Lodish HF
    Haematologica; 2010 Dec; 95(12):2013-21. PubMed ID: 20823130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression.
    Illi B; Nanni S; Scopece A; Farsetti A; Biglioli P; Capogrossi MC; Gaetano C
    Circ Res; 2003 Jul; 93(2):155-61. PubMed ID: 12805238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of chromatin and chromosome morphology by histone H3 modifications in pig oocytes.
    Bui HT; Van Thuan N; Kishigami S; Wakayama S; Hikichi T; Ohta H; Mizutani E; Yamaoka E; Wakayama T; Miyano T
    Reproduction; 2007 Feb; 133(2):371-82. PubMed ID: 17307905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.
    Ciesielski O; Biesiekierska M; Balcerczyk A
    Molecules; 2020 May; 25(10):. PubMed ID: 32429384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CG0006, a novel histone deacetylase inhibitor, induces breast cancer cell death via histone-acetylation and chaperone-disrupting pathways independent of ER status.
    Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Hyun YL; Choi J
    Breast Cancer Res Treat; 2011 Nov; 130(2):365-75. PubMed ID: 21184271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells.
    Mishra SK; Mandal M; Mazumdar A; Kumar R
    FEBS Lett; 2001 Oct; 507(1):88-94. PubMed ID: 11682064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells.
    Hitchler MJ; Oberley LW; Domann FE
    Free Radic Biol Med; 2008 Dec; 45(11):1573-80. PubMed ID: 18845242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells.
    Gregory RI; O'Neill LP; Randall TE; Fournier C; Khosla S; Turner BM; Feil R
    J Biol Chem; 2002 Apr; 277(14):11728-34. PubMed ID: 11821379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone H4 hyperacetylation precludes histone H4 lysine 20 trimethylation.
    Sarg B; Helliger W; Talasz H; Koutzamani E; Lindner HH
    J Biol Chem; 2004 Dec; 279(51):53458-64. PubMed ID: 15456746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.